A Feasibility Trial of Power Up: Smartphone App to Support Patient Activation and Shared Decision Making for Mental Health in Young People.


Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
04 06 2019
Historique:
received: 25 07 2018
accepted: 24 10 2018
revised: 22 10 2018
entrez: 6 6 2019
pubmed: 6 6 2019
medline: 6 6 2019
Statut: epublish

Résumé

Digital tools have the potential to support patient activation and shared decision making in the face of increasing levels of mental health problems in young people. There is a need for feasibility trials of digital interventions to determine the usage and acceptability of interventions. In addition, there is a need to determine the ability to recruit and retain research participants to plan rigorous effectiveness trials and, therefore, develop evidence-based recommendations for practice. This study aimed to determine the feasibility of undertaking a cluster randomized controlled trial to test the effectiveness of a smartphone app, Power Up, co-designed with young people to support patient activation and shared decision making for mental health. Overall, 270 young people were screened for participation and 52.5% (142/270) were recruited and completed baseline measures across 8 specialist child mental health services (n=62, mean age 14.66 (SD 1.99) year; 52% [32/62] female) and 2 mainstream secondary schools (n=80; mean age 16.88 [SD 0.68] years; 46% [37/80] female). Young people received Power Up in addition to management as usual or received management as usual only. Posttrial interviews were conducted with 11 young people from the intervention arms (specialist services n=6; schools n=5). Usage data showed that there were an estimated 50 (out of 64) users of Power Up in the intervention arms. Findings from the interviews indicated that young people found Power Up to be acceptable. Young people reported (1) their motivation for use of Power Up, (2) the impact of use, and (3) barriers to use. Out of the 142 recruited participants, 45.0% (64/142) completed follow-up measures, and the approaches to increase retention agreed by the steering group are discussed. The findings of this study indicate that the app is acceptable, and it is feasible to examine the effectiveness of Power Up in a prospective cluster randomized controlled trial. ClinicalTrials.gov NCT02552797; https://clinicaltrials.gov/ct2/show/NCT02552797 (Archived by WebCite at http://www.webcitation.org/6td6MINP0).

Sections du résumé

BACKGROUND
Digital tools have the potential to support patient activation and shared decision making in the face of increasing levels of mental health problems in young people. There is a need for feasibility trials of digital interventions to determine the usage and acceptability of interventions. In addition, there is a need to determine the ability to recruit and retain research participants to plan rigorous effectiveness trials and, therefore, develop evidence-based recommendations for practice.
OBJECTIVE
This study aimed to determine the feasibility of undertaking a cluster randomized controlled trial to test the effectiveness of a smartphone app, Power Up, co-designed with young people to support patient activation and shared decision making for mental health.
METHODS
Overall, 270 young people were screened for participation and 52.5% (142/270) were recruited and completed baseline measures across 8 specialist child mental health services (n=62, mean age 14.66 (SD 1.99) year; 52% [32/62] female) and 2 mainstream secondary schools (n=80; mean age 16.88 [SD 0.68] years; 46% [37/80] female). Young people received Power Up in addition to management as usual or received management as usual only. Posttrial interviews were conducted with 11 young people from the intervention arms (specialist services n=6; schools n=5).
RESULTS
Usage data showed that there were an estimated 50 (out of 64) users of Power Up in the intervention arms. Findings from the interviews indicated that young people found Power Up to be acceptable. Young people reported (1) their motivation for use of Power Up, (2) the impact of use, and (3) barriers to use. Out of the 142 recruited participants, 45.0% (64/142) completed follow-up measures, and the approaches to increase retention agreed by the steering group are discussed.
CONCLUSIONS
The findings of this study indicate that the app is acceptable, and it is feasible to examine the effectiveness of Power Up in a prospective cluster randomized controlled trial.
TRIAL REGISTRATION
ClinicalTrials.gov NCT02552797; https://clinicaltrials.gov/ct2/show/NCT02552797 (Archived by WebCite at http://www.webcitation.org/6td6MINP0).

Identifiants

pubmed: 31165709
pii: v7i6e11677
doi: 10.2196/11677
pmc: PMC6682268
doi:

Banques de données

ClinicalTrials.gov
['NCT02552797']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e11677

Informations de copyright

©Julian Edbrooke-Childs, Chloe Edridge, Phoebe Averill, Louise Delane, Chris Hollis, Michael P Craven, Kate Martin, Amy Feltham, Grace Jeremy, Jessica Deighton, Miranda Wolpert. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 04.06.2019.

Références

Patient Educ Couns. 2010 Jul;80(1):94-9
pubmed: 19879711
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
J Med Internet Res. 2017 May 25;19(5):e176
pubmed: 28546138
Clin Psychol Psychother. 2017 Nov;24(6):O1495-O1511
pubmed: 28752631
J Abnorm Psychol. 2017 Feb;126(2):212-224
pubmed: 27929304
J Clin Nurs. 2006 Jan;15(1):61-71
pubmed: 16390525
Clin Psychol Rev. 2014 Aug;34(6):506-17
pubmed: 25189522
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
JMIR Mhealth Uhealth. 2016 Mar 23;4(1):e31
pubmed: 27009498
Health Expect. 2015 Aug;18(4):542-61
pubmed: 23451939
JMIR Form Res. 2019 May 02;3(2):e11958
pubmed: 31045499
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
Qual Life Res. 2010 Aug;19(6):875-86
pubmed: 20405245
Br J Psychiatry. 1990 Mar;156:384-7
pubmed: 2346839
BMJ Open. 2017 Feb 17;7(2):e013537
pubmed: 28213598
Behav Modif. 2015 Nov;39(6):785-804
pubmed: 26187164
JMIR Ment Health. 2018 Feb 23;5(1):e16
pubmed: 29475823
Clin Child Psychol Psychiatry. 2016 Apr;21(2):324-38
pubmed: 26104790
J Child Psychol Psychiatry. 2017 Apr;58(4):474-503
pubmed: 27943285
Clin Child Psychol Psychiatry. 2016 Jan;21(1):19-31
pubmed: 25178946
Gen Hosp Psychiatry. 2009 Jan-Feb;31(1):36-45
pubmed: 19134509
Am J Psychiatry. 2009 Sep;166(9):1002-10
pubmed: 19651711
Patient Educ Couns. 2013 Oct;93(1):102-7
pubmed: 23768763
Br J Psychiatry. 1988 Feb;152:201-4
pubmed: 3167336
J Am Acad Child Adolesc Psychiatry. 1990 Jul;29(4):657-60
pubmed: 2387803
J Med Internet Res. 2017 Nov 01;19(11):e367
pubmed: 29092808
Med Care. 2008 Mar;46(3):247-56
pubmed: 18388839
JMIR Res Protoc. 2017 Oct 30;6(10):e206
pubmed: 29084708
Health Expect. 2004 Sep;7(3):235-45
pubmed: 15327462

Auteurs

Julian Edbrooke-Childs (J)

Evidence Based Practice Unit, University College London and the Anna Freud National Centre for Children and Families, London, United Kingdom.

Chloe Edridge (C)

Evidence Based Practice Unit, University College London and the Anna Freud National Centre for Children and Families, London, United Kingdom.

Phoebe Averill (P)

Evidence Based Practice Unit, University College London and the Anna Freud National Centre for Children and Families, London, United Kingdom.

Louise Delane (L)

Evidence Based Practice Unit, University College London and the Anna Freud National Centre for Children and Families, London, United Kingdom.

Chris Hollis (C)

National Institute of Health Research MindTech MedTech Co-operative, Nottingham, United Kingdom.
National Institute of Health Research Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom.

Michael P Craven (MP)

National Institute of Health Research MindTech MedTech Co-operative, Nottingham, United Kingdom.
National Institute of Health Research Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Bioengineering Research Group, Faculty of Engineering, University of Nottingham, Nottingham, United Kingdom.

Kate Martin (K)

Common Room Consulting Limited, London, United Kingdom.

Amy Feltham (A)

Common Room Consulting Limited, London, United Kingdom.

Grace Jeremy (G)

Common Room Consulting Limited, London, United Kingdom.

Jessica Deighton (J)

Evidence Based Practice Unit, University College London and the Anna Freud National Centre for Children and Families, London, United Kingdom.

Miranda Wolpert (M)

Evidence Based Practice Unit, University College London and the Anna Freud National Centre for Children and Families, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH